Market Value Exceeds 10 Billion: First Percutaneous Surgery Robot Listed on HKEX
- Published
- Source
- leaderobot.com
Guangdong Zhenjiankang Medical Technology Co., Ltd. made its debut on the Hong Kong Stock Exchange, marking a significant milestone as the first company specializing in percutaneous surgery robots. On its first day of trading, the company's stock skyrocketed by 216.96%, propelling its market capitalization to HKD 14.259 billion. Zhenjiankang's focus on advanced percutaneous and ablation surgery technologies has positioned it as a leader in the Chinese market, underscoring its impressive revenue growth driven by innovative products and strong clinical validation.
Original report
Market Value Exceeds 10 Billion: First Percutaneous Surgery Robot Listed on HKEX
leaderobot.com · LeaderobotThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
